0 CHECKOUT

Taiwan Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3388106
  • August 2015
  • Region: Taiwan
  • 130 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Empax Pharma
  • GlaxoSmithKline (GSK)
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

Taiwan will remain a key destination for clinical trials due to the government's efforts to augment the country's medical infrastructure and streamline clinical research regulatory processes. In addition, there will be further upsides to the clinical trials sector should Taiwan be able to successfully harmonise its regulations with China and allow for the mutual recognition of data.

Headline Expenditure Projections
- Pharmaceuticals: TWD167.7bn (USD5.5bn) in 2014 to TWD175.1bn (USD5.6bn) in 2015; +4.4% in local currency terms and +0.5% in US dollar terms. Unchanged from previous quarter.

- Healthcare: TWD1,005.4bn (USD33.2bn) in 2014 to TWD1,046.8bn (USD33.2bn) in 2015; +4.1% in local currency terms and +0.3% in US dollar terms. Forecast maintained from previous quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Empax Pharma
  • GlaxoSmithKline (GSK)
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Taiwan 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Taiwan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Taiwan 2013-2019)

Key Risks To Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: Economic Activity (Taiwan 2010-2019)

Industry Risk Reward Indices

Asia Pacific Risk/Reward Index

Taiwan Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Healthcare System

Healthcare Insurance
Table: Sources Of Financing
Table: Healthcare Resources (Taiwan 2009-2014)
Table: Healthcare Personnel (Taiwan 2009-2014)
Table: Healthcare Activity (Taiwan 2009-2014)

Healthcare Financing
Table: Taiwan Insurance Coverage

Medical Tourism

Traditional Chinese Medicine

Biotechnology Sector

Vaccines

Clinical Trials

Telecare

Regulatory Development
Table: Medicine Categories In Taiwan
Table: Examples Of Controlled Drugs In Taiwan

Recent Regulatory Developments

Intellectual Property Regime

Pricing Regime

Reimbursement Regime
Table: Reimbursement System in Taiwan
Table: Drug Reimbursement Principles
Table: BNHI Spending By Type Of Outpatient Claims, As Percentage Of Total

Competitive Landscape
Table: Corporate Member Companies Of IRPMA
Table: Top-20 Pharmaceutical & Biotechnology Firms In Taiwan According To Market Capitalisation (USDmn)
Table: TGPA Members, 2012

Pharmaceutical Wholesale
Table: Western Drug Distributors 2006-2010

Pharmaceutical Retail
Table: Pharmacies, 2006-2010

Company Profile

Empax Pharma

GlaxoSmithKline (GSK)

Merck & Co

Novartis

Pfizer

Sanofi

ScinoPharm Taiwan

TaiGen

Yung Shin Pharmaceutical (YSP)

Demographic Forecast
Table: Population Headline Indicators (Taiwan 1990-2025)
Table: Key Population Ratios (Taiwan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Taiwan 1990-2025)
Table: Population By Age Group (Taiwan 1990-2025)
Table: Population By Age Group % (Taiwan 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Empax Pharma
GlaxoSmithKline (GSK)
Merck & Co
Novartis
Pfizer
Sanofi
ScinoPharm Taiwan
TaiGen
Yung Shin Pharmaceutical (YSP)

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Cache

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.